Alterations in the RB, p16, and cyclin D1 cell cycle control pathway in osteosarcomas

Pediatric Pathology and Molecular Medicine

Volumn 19, Issue 5, 2000, Pages 377-389

  Belchis, D A ^a   Gocke, C D ^a   Geradts, J ^a  

^a Northwest Hospital   (United States)

Author keywords

Cyclin D1; Immunohistochemistry; Loss of heterozygosity; Osteosarcoma; p16; RB; Retinoblastoma

Indexed keywords

CYCLIN D1; PROTEIN P16;

ADOLESCENT; ADULT; ANIMAL CELL; ANTIGEN RETRIEVAL; ARTICLE; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; OSTEOSARCOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RETINOBLASTOMA; SCHOOL CHILD; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 0033692380     PISSN: 15227952     EISSN: None     Source Type: Journal    
DOI: 10.1080/15513810009168646     Document Type: Article

References (33)

1. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis
2. Rb and p16INK4a expression in resected non-small cell lung tumors
3. Tumor-suppressive pathways in pancreatic carcinoma
4. Involvement of the retinoblastoma gene in primary osteosarcomas and other bone and soft-tissue tumors
5. The gene responsible for the development of retinoblastoma and osteosarcoma
6. Cytogenetic findings in 73 osteosarcoma specimens and a review of the literature
7. Loss of heterozygosity and microsatellite instability at the retinoblastoma locus in osteosarcomas
8. Chromosome 13 homozygosity in osteosarcoma without retinoblastoma
9. Osteosarcoma and retinoblastoma: A shared chromosomal mechanism revealing recessive predisposition
10. Molecular genetic considerations in osteosarcoma
11. Complete association of loss of heterozygosity of chromosomes 13 and 17 in osteosarcoma
12. Mutation spectrum of the retinoblastoma gene in osteosarcomas
13. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma
14. Alterations of the p15, p16, and p18 genes in osteosarcoma
15. Cytogenetic aberrations in osteosarcomas. Nonrandom deletions, rings, and double-minute chromosomes
16. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations
17. Altered G1 phase regulation in osteosarcoma
18. Retinoblastoma protein monoclonal antibodies with novel characteristics
19. Wild-type and mutant retinoblastoma protein in paraffin sections
20. Abrogation of cell cycle control in human mesenchymal neoplasia
21. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers
22. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: Correlation with retinoblastoma protein expression
23. Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies
24. A method for PCR sequencing of the p53 gene from a single 10-microns frozen or paraffin-embedded tissue section
25. Alterations of the p53, Rb and MDM2 genes in osteosarcoma
26. Preferential mutation of paternally derived RB gene as the initial event in sporadic osteosarcoma
27. Allelotype analysis in osteosarcomas: Frequent allele loss on 3q, 13q, 17p, and 18q
28. Antibodies detecting abnormalities of the retinoblastoma susceptibility gene product (pp110RB) in osteosarcomas and synovial sarcomas
29. Studies of the retinoblastoma gene in human sarcomas
30. CDK4 gene amplification in osteosarcoma: Reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons
31. Loss of heterozygosity of the RB gene is a poor prognostic factor in patients with osteosarcoma
32. Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma
33. Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus